
Suresh S. Ramalingam, MD, FASCO, Winship Cancer Institute of Emory University
Advertisement
Articles by Suresh S. Ramalingam, MD, FASCO, Winship Cancer Institute of Emory University

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma
2
FDA Accepts sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis
3
Beyond the Target: Payloads, Therapeutic Windows, and Biomarkers Shape the Next Wave of ADCs in NSCLC
4
Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC
5

